ABSTRACT: Novel lipid derivatives carrying amino and triazolyl groups were efficiently synthesized and covalently anchored at the 3'-termini of oligonucleotides. The desired amino lipid-conjugates were fully characterized by reverse phase HPLC and MALDI-TOF mass spectrometry. The methodology was applied to the synthesis of lipid-siRNA designed to inhibit tumor necrosis factor (TNF-a) in order to obtain siRNAs with anti-inflammatory properties. The siRNA duplex carrying amino-lipids at the 3'-end of the passenger strand has similar inhibitory properties to unmodified RNA duplexes in HeLa cells indicating that the new lipid derivatives are compatible with the RNA interference machinery.
nature. To overcome these limitations, different strategies have been employed and non-viral vectors have emerged as a promising alternative to gene delivery. 5 The most used carriers for DNA and RNA oligonucleotides are cationic lipids and liposomes which promote cellular uptake of antisense and RNAi therapies 6 although their mechanism is still unclear and controversial. In general, the use of targeted lipoplexes as systems to mediate siRNA delivery has become the most reported method. 7, 8 These units, which maintain an electrostatic association, are often unstable 9 and should be prepared before use, so other alternative and robust linkage methods between siRNAs and non-viral vectors may be developed and validated. Recently it has been demonstrated that nanoparticles can be used for the efficient delivery of siRNA.
10
Lipid-oligonucleotide conjugates are an interesting alternative. Some years ago, lipid-oligonucleotide conjugates were found to improve biological activity of triplex-forming and antisense oliognucleotides. 11 Recently, a few examples on the use of siRNA covalently conjugated to lipids have been described in the literature. Cholesterol, 12 fatty acids derivatives 12 and α-tocopherol 13 have been efficiently linked to the 5'-ends (phosphoramidite chemistry) and 3'-ends (CPG supports) of the siRNA guide and passenger strands. Further biological evaluations of these conjugates showed that the introduction of these groups did not affect the RNAi machinery obtaining high levels of inhibition in the gene expression.
As a part of our ongoing interest in the development of chemically modified DNA and siRNAs to inhibit gene expression, 14 we have been looking into the possibility of synthesizing siRNA conjugates by linking lipid molecules with different polar and / or protonatable groups (such as amines and triazoles) at the 3'-termini of the siRNA duplex (Scheme 1). We aimed to mimic the effect produced by lipoplex complexes. As far as we know, such complex lipids have never been introduced into siRNA.
Finally, the effects of such modifications on the RNAi machinery were measured through the evaluation of these chemically modified lipid-siRNA conjugates in the regulation of the TNF-α gene expression. SCHEME 1. Structure of the lipid oligonucleotide conjugates described in this study. . Moreover, aminodiols such as 4-aminoprolinol 12d have the advantage of well defined chirality. But the use of this type of linkers needs the use of fatty acids functionalized at the other end of the hydrocarbon chain for the preparation of amino-lipids. These compounds are not easily available. In contrast, trihydroxy compounds can be used if ether or urethane bonds are used to connect the lipid to the triols. In these cases the resulting lipid derivatives usually generate diastereoisomeric mixtures, but the presence of isomers are not considered a serious problem for biological activity of the resulting siRNA. Moreover disubstituted alkanes needed for the preparation of the lipid derivatives are available.
For these reasons we considered the use of a glycerol backbone (Scheme 1) as suitable linker for introducing our chemical modifications at the 3'-end of the siRNA duplexes. This linker when reacted with phosphoramidites will produce a phosphate bond that will be stable to ammonia deprotection conditions used in oligonucleotide synthesis. Also, it allows the incorporation of the lipid derivative to a solid support. the desired trityl derivative 6 in 58% yield after purification by flash chromatography.
Click chemistry, on the other hand, is considered to be a modular approach that is increasingly found in all aspects of drug discovery, combinatorial chemistry and recently, in nucleic acid chemistry 16 , easily obtaining triazolyl rings. 17 Taking this into account, we considered exploring the use of the 1,3-dipolar cycloadditions between the previously synthesized azide 3 and some commercially available alkynes 18 in order to study the subsequent effect that these kind of rings could exercise on the RNAi machinery.
Then, the click reactions were carried out under standard conditions 19 to give the desired triazoles compounds 8 and 9 as only regioisomers in 89% and 59% yield respectively after purification by flash chromatography (Scheme 3).
In order to obtain the corresponding trityl derivatives, compounds 8 and 9 were subjected to acetonide hydrolysis in different acid conditions (DCM:TFA 3% for acetonide 8; pTsOH in the presence of methanol for acetonide 9, respectively) yielding the requisite diols 10 and 11 in 72% and 99% yield respectively. Trityl derivative 13 was directly obtained from protecting alcohol 10 with DMTr under the same conditions previously mentioned in 39% yield. Finally, the synthesis of last trityl derivative 14 was carried out as follows: the phthalimide 11 was removed under basic hydrolysis to give the expected amine which was then subsequently protected with ethyl trifluoroacetate yielding the N-protected amine
12.
Finally, the selective protection of primary alcohol 12 with 4-monomethoxytrityl (MMTr) afforded the corresponding protected trityl alcohol 14 in 45% yield. The three trityl compounds 6, 13 and 14 were coupled with CPG supports using the succinyl linker as described. 20 For this purpose, the DMTr and MMTr-derivatives described above reacted with succinic anhydride followed by coupling the resulting hemisuccinates with amino-functionalized CPG which yielded glass beads containing lipids 7 (21 µmol/g), 15 (25 µmol/g) and 16 (23 µmol/g), respectively.
CPG functionalization was determined by the measure of the absorbance of the DMTr / MMTr cations released from the support upon acid treatment.
Oligodeoxyribonucleotide synthesis. First, we synthesized a short oligodeoxynucleotide sequence to demonstrate the stability of the lipid derivative to phosphoramidite synthesis conditions. The selfcomplementary Dickerson-Drew dodecamer sequence (5'-CGCGAATTCGCG-3') was used as a model sequence. The sequence was assembled on CPG solid supports 7, 15 and 16 using standard protocols in order to generate the corresponding lipid-oligonucleotide conjugates by using DMT off-based protocols.
After cleavage with ammonia solution (32%) followed by HPLC purification the corresponding modified aminolipid-oligonucleotide conjugates (17) (18) (19) were obtained and confirmed by MALDI-TOF mass spectrometry (MS) ( Table 1) . *conditions: sodium phosphate 10 mM, NaCl NaCl, pH 7.0, in these conditions unmodified DickersonDrew dodecamer melted at 49 ºC; n.d. not determined.
In addition, we studied the conversion of the amino group to the guanidinium group in order to extend the possibility of cationic charge enrichment in our synthesized aminolipid-oligonucleotide conjugates
17-19.
The synthesis of certain guanidinium derivatives of nucleic acids has been described in the literature 21 and some of them have been synthesized through post-synthetic modification. 14a,21e The guanidinium-modified ONs synthesized during this study are summarized on Table 1 . In all cases, selective and quantitative guanidinylation were observed following a classical post-synthetic approach 21e on oligonucleotides 17-19 which were reacted with O-methylisourea for 16 hr at 55ºC.
After desalting, the guanidinylated compounds 20-22 (Scheme 4) were analyzed by analytical HPLC and characterized by MALDI experiments. Melting temperatures of the synthesized lipid-modified dodecamers were higher than unmodified dodecamer (see Table 1 ). A similar effect has been also observed recently with the dodecamer modified with arginine and lysine residues as well as lipids.
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. SCHEME 4. Synthesis of the amine and guanidinium oligonucleotides Oligoribonucleotide synthesis. All oligoribonucleotides were synthesized using solid supports 7, 15
and 16 (1.0 µmol each) using a DNA/RNA synthesizer (sequences of guide and passenger strands are shown in Tables 1 and 2 ). Modified RNA oligonucleotides linked to the aforementioned solid supports were released according to DMT on-based protocols and then crude modified oligoribonucleotides were first purified by HPLC followed by DMTr deprotection with AcOH 80%. Finally, amino lipid-RNA conjugates (23-25) were again analyzed by reversed phase HPLC and characterized by MALDI-TOF mass spectrometry (Table 1) . siRNA duplexes (siRNA2, siRNA3 and siRNA4, respectively) were obtained by annealing of equal molar amounts of passenger (sense) and guide (antisense) strands, which were purified by ethanol precipitation protocol (see Experimental Part). siRNAs are shown with the passenger strand above (5' -3') and the guide strand below (3' -5'). T stands for thymidine.
Gene silencing by modified siRNAs. The gene silencing effect on the TNF-α messenger RNA of several siRNAs: one native siRNA1, three chemically modified siRNAs (siRNA2, siRNA3 and siRNA4) and one scrambled siRNA5 were studied. HeLa cells were first co-transfected with plasmid pCAm TNF-α by using commercial cationic liposomes (Lipofectamine-2000) . We then carried out the transfection of the aforementioned siRNA derivatives with oligofectamine. Forty-eight hours after transfection, the amount of TNF-α produced by the cells was analyzed by enzyme-linked immunosorbent assay (ELISA). The silencing activities are depicted on Figure 1 . In general, all chemically modified siRNAs previously obtained maintained their abilities to down-regulate TNF-α protein expression levels to around 65% at 50 nM concentration compared with the scrambled control siRNA5 duplex. These results indicate that the introduction of all the proposed modifications at the 3'-termini of the passenger strand of an RNA duplex is compatible with the RNAi machinery in HeLa cells. HPLC conditions. Conditions for semipreparative HPLC: HPLC solutions were solvent A: 5% acetonitrile (ACN) in 100 mM triethylammonium acetate (TEAA), pH 6.5 and solvent B: 70 % ACN in 100 mM triethylammonium acetate (pH 6.5). Column: PRP-1 (Hamilton) 250x 10 mm. Flow rate 3 ml/min linear gradient from 15 to 100% in B (DMTon) and 0 to 50% in B (DMToff) was used with UV detection at 260 nm. Conditions for analytical HPLC: HPLC solutions were solvent A: 5% acetonitrile (ACN) in 100 mM triethylammonium acetate (TEAA), pH 6.5 and solvent B: 70 % ACN in 100 mM triethylammonium acetate (pH 6.5). Column: XBridge OST C18 2.5 μm. Flow rate 1ml/min linear gradient from 0 to 50% in B (DMToff) were used with UV detection at 260 nm.
4-((12-bromododecyloxy)methyl)-2,2-dimethyl-1,3-dioxolane, 2. Alcohol 1 (200 mg; 1.51 mmol) was reacted with dibutyltin oxide (751 mg, 3.02 mmol; 2.0 eq) in dry methanol (10 mL) at reflux for 3h, followed by removing the methanol and any traces of water using azeotropic distillation with toluene.
The reaction mixture was concentrated and then, 1,12-dibromododecane (991 mg, 3.02 mmol; 2.0 eq), cesium fluoride (458 mg, 3.02 mmol; 2.0 eq) and dry DMF (10 mL) were added. The reaction mixture was kept at room temperature overnight. 
4-((12-azidododecyloxy)methyl)-2,2-dimethyl-1,3-dioxolane, 3. Compound 2 (100 mg, 0.264 mmol)
was dissolved in 5 mL of anhydrous DMF. NaN 3 (103 mg, 1.58 mmol; 6.0 eq) was then added and the mixture was stirred and heated to 70 ºC for 48 h. The reaction was cooled at 0ºC and water was added carefully. The solvent was evaporated and the resulting oil was then purified by flash chromatography tert-butyl 12-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)dodecylcarbamate, 4. Azide 3 (85 mg, 0.249 mmol) along with PPh 3 (131 mg, 0.498 mmol; 2.0 eq) were dissolved in 3 mL of anhydrous THF. The reaction was stirred for 2 hours at room temperature. Subsequently, water (500 uL) was added dropwise.
The mixture was stirred overnight at room temperature. The solvent was evaporated and the crude was dried by pressure, yielding the anticipated amine. This amine was dissolved in 2.0 mL of anhydrous DCM; TEA (69 μL, 0.498 mmol; 2.0 eq) was added dropwise along with Boc 2 O (82 mg, 0.373 mmol;
1.5 eq). The reaction was stirred for 5 hours at room temperature. The organic layer was extracted with more DCM (5 mL) and rinsed with water (3 x 10 mL). The organic layer was dried on anhydrous Na 2 SO 4 . The solvent evaporated and the resulting residue was purified by flash chromatography (Ch:AcOEt 4% to 9 %): Yield: 65%; IR (film) 3020, 2935, 2850, 1699, 1506, 1371, 1216, 1166, 1046 1.2 eq) and DMAP (8 mg, 0.07 mmol; 0.5 eq) were dissolved in 1.5 mL of anhydrous pyridine. The reaction was heated at 40 ºC and stirred overnight. Methanol (0.5 mL) was added and the solvent evaporated. The resulting product was purified by flash chromatography (Hex/AcOEt 15%): Yield: 58%; IR (film) 3276, 3072, 2927, 2851, 1716, 1673, 1607, 1502, 1462, 1390, 1248, 1176 , 1038 cm 7, 158.6, 149.9, 145.0. 136.3, 136.2, 130.2, 128.3, 127.9, 126.9, 123.9, 113.2, 86.2, 72.3, 71.8, 70.1, 64.7, 55.4, 55.3, 55.3, 50.8, 40.2, 36.6, 31.6, 29.9, 29.8, 29.7, 29.7, 29.6, 29.6, 29.6, 29.3, 29.1, 26.8, 26 General procedure for the click reaction (8 and 9) . Azide 3 (1.0 eq) and selected alkynes (1.0 eq) were suspended in a 1:1 mixture of water and tert-butyl alcohol (1.0 mL). Sodium ascorbate (10%) and copper (II) sulphate pentahydrate (1%) were added dropwise. The heterogeneous mixture was stirred vigorously overnight. The reaction mixture was diluted with DCM and the organic layer was washed with water (3x5 mL). The organic layer was dried with anhydrous Na 2 SO 4 and solvent evaporated. The resulting oil was purified by flash chromatography. 7, 29.7, 29.7, 29.6, 29.5, 29.2, 28.2, 26.9, 26.8, 26.7, 26.2, 25.6, 25.3 2, 29.5, 29.5, 29.4, 29.4, 29.3, 28.9, 26.7, 26.4, 26.0, 25.4 4, 143.6, 141.1, 127.5, 126.8, 124.9, 119.8, 72.3, 71.6, 70.3, 70.2, 66.7, 64.0, 53.2, 50.6, 47.0, 29.9, 29.5, 29.3, 29.2, 29.2, 29.2, 29.2, 29.1, 28.7, 26.3, 25.8 99%; IR (film) 3349, 2924, 2850, 1684, 1517, 1251, 1170, 1123, 1046 6, 134.1, 132.3, 123.4, 72.7, 72.0, 70.6, 64.4, 50.4, 37.8, 30.5, 29.7, 29.6, 29.6, 29.6, 29.5, 29.5, 29.1, 28.2, 26.8, 26.6, 26.2, 25.3 ºC. The solvent was reduced to dryness and the resulting product was dissolved again in anhydrous DCM (1.5 mL). TEA (38uL) was added dropwise at room temperature. The reaction was cooled at 0ºC
2-(4-(1-(12-((
and EFTA (8.0 uL) was added dropwise. The reaction was stirred for 30 minutes at 0ºC. The organic layer was washed with water and brine (3 x 10 mL) and dried with anhydrous Na 2 SO 4 and evaporated.
The resulting compound was used in the next step without further purification. The compound obtained, along with MMTrCl (27.8 mg, 0.09 mmol; 1.5 eq) and DMAP (4.0 mg, 0.03 mmol; 0.5 eq) were dissolved in 1.0 mL of pyridine. The reaction was heated at 40 ºC and stirred overnight. Methanol was added (1.0 mL) and the solvent evaporated. The product was then purified by flash chromatography 6, 150.0, 147.4, 145.0, 136.2, 130.2, 128.3, 128.0, 126.9, 124.0, 123.8 (q, J = 298.1 Hz, CF 3 ), 120.9, 113.2, 86.2, 72.3, 71.8, 70.1, 64.6, 55.4, 50.4, 39.8, 30.5, 29.8, 29.7, 29.6, 29.5, 29.2, 28.1, 26.7, 26.4, 26.3, 24.9; 19 F-NMR δ -73. 8, 156.6, 144.6, 144.0, 141.5, 135.7, 130.5, 128.7, 128.6, 128.0, 127.9, 127.2, 1271, 125.2, 122.2, 120.0, 113.3, 86.5, 72.3, 71.8, 70.0, 67.0, 64.7, 55.4, 50.6, 47.4, 46.4, 36.7, 30.4, 29.8, 29.7, 29.7, 29.6, 29.5, 29.2, 26.7, 26.7, 26.3 
Synthesis of amine oligonucleotides (17-19).
Oligonucleotide synthesis was carried out in an automated DNA synthesizer on a 1.0 μmol scale using CPG resins 7, 15, 16. The synthesis followed the regular protocol for the DNA synthesizer. After a final detritylation, the oligonucleotides were removed from the universal solid support by treatment with concentrated ammonia at 55 °C for 20 h. After desalting (Sephadex G-25, NAP-10), pure aminolipid-oligonucleotide conjugates 17-19 were obtained. Melting Experiments. UV melting experiments were carried out on a UV spectrometer. Samples were dissolved in a medium salt buffer containing Na 2 HPO 4 (5 mM), NaH 2 PO4 (10 mM), NaCl (100 mM).
Synthesis of guanidin-oligonucleotides
The increase in absorbance at 260 nm as a function of time was recorded while the temperature was increased linearly from 20 to 90 °C at a rate of 0.5 °C/min by means of a Peltier temperature programmer. The melting temperature was determined by the local maximum of the first derivatives of the absorbance vs. temperature curve. All melting curves were found to be reversible. All determinations are averages of triplicates.
Oligoribonucleotide synthesis. The following RNA sequences were obtained from commercial sources siRNA duplexes. The chemically modified sense or passanger strand and antisense or guide strand
